image

The best stocks to buy since 1993

Latest issue now available

Supreme - Upgrade cycle resuming

December 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SUP
  • Price:
  • 99.5p
At the heart of the battle for the pound in smokers’ pockets are sweet smells and delicious tastes in the form of vapes; it is often the fragrance or the flavour that determines which sells the best and vapes have been emerging as a particularly buoyant sector set to grow 25-30% a year until 2030. The positive outlook for vaping is also highlighted in the recent 9 June Government report, ‘Making smoking obsolete,’ which notes “the government must embrace the promotion of vaping as an effective tool to help people to quit smoking; indeed the NHS plans are already underway for  prescription Vapes in 2 years. In the quoted space, the scale of the opportunity is indicated by the progress of Supreme’s (SUP; 99.5p) vaping division. Duri ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe